MedTrace Logo

Evaluation of the Benefits of Sublingual AIT (PRACTIS)

NCT06574061 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1635

Last updated 2024-08-29

No results posted yet for this study

Summary

The objective of the study was to evaluate in routine practice the benefits of sublingual allergen immunotherapy (SLIT) for allergic patients with allergic rhinitis (AR), with or without asthma, according to various methods of use (treatment regimen: formulation type, dose, duration, initiation) and type of allergen (grass pollen, tree pollen, herbaceous pollen, house dust mites, animal dander, moulds and poly-reactive types).

Conditions

  • Allergic Rhinitis

Sponsors & Collaborators

  • Stallergenes Greer

    lead INDUSTRY

Principal Investigators

  • Pascal DEMOLY, Professor · CHU & IDESP, Montpellier, France

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-29
Primary Completion
2020-07-22
Completion
2021-10-14

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06574061 on ClinicalTrials.gov